Inactive Instrument
Evolutionary Genomics, Inc. Stock Other OTC
Stocks
FNAM
US30051F1012
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 2.99M 2.67M 2.49M 2.26M 4.26M 285M 4.29M 29.82M 11.68M 148M 11.25M 11M 474M | P/E 2021 |
-1.34x | P/E 2022 | -2x |
|---|---|---|---|---|---|
| Enterprise Value | 6.16M 5.5M 5.13M 4.65M 8.76M 587M 8.82M 61.35M 24.02M 304M 23.14M 22.63M 976M | EV / Sales 2021 |
-
| EV / Sales 2022 | - |
| Free-Float |
67.35% | Yield 2021 * |
-
| Yield 2022 | - |
| 1 day | -10.00% |
| Manager | Title | Age | Since |
|---|---|---|---|
Walter Messier
CTO | Chief Tech/Sci/R&D Officer | 71 | 1999-12-31 |
Steve Warnecke
CEO | Chief Executive Officer | 70 | 2014-09-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Steve Warnecke
CHM | Chairman | 70 | 2014-09-30 |
| Director/Board Member | 76 | 1999-12-31 | |
Mark Boggess
BRD | Director/Board Member | 66 | 2009-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -10.00% | -.--% | - | - | 1.33K | ||
| -0.32% | -5.97% | +50.26% | +76.20% | 70.65B | ||
| -1.99% | -11.55% | +4.84% | +49.58% | 51.22B | ||
| -1.32% | -1.46% | +7.39% | +31.23% | 48.04B | ||
| -0.58% | -2.03% | +31.54% | +31.92% | 43.16B | ||
| -2.84% | -9.26% | +290.63% | +678.68% | 41.57B | ||
| -0.38% | -3.48% | +9.05% | +98.08% | 39.84B | ||
| -0.39% | -1.59% | +8.69% | +42.99% | 30.87B | ||
| -2.66% | -7.49% | +35.37% | +3.22% | 27.53B | ||
| -7.13% | -8.84% | -12.79% | -18.26% | 24.08B | ||
| Average | -2.76% | -3.92% | +47.22% | +110.40% | 41.88B | |
| Weighted average by Cap. | -1.60% | -4.29% | +50.12% | +116.45% |
| 2021 | 2022 | |
|---|---|---|
| Net sales | - | - |
| Net income | -2.79M -2.5M -2.33M -2.11M -3.97M -266M -4M -27.82M -10.89M -138M -10.49M -10.26M -442M | -1.93M -1.73M -1.61M -1.46M -2.75M -184M -2.77M -19.27M -7.54M -95.5M -7.27M -7.11M -306M |
| Net Debt | 3.53M 3.15M 2.94M 2.66M 5.02M 336M 5.06M 35.14M 13.76M 174M 13.26M 12.96M 559M | 3.17M 2.83M 2.64M 2.39M 4.5M 302M 4.54M 31.53M 12.35M 156M 11.89M 11.63M 501M |
Employees
-
















